Guangxi Z. Zhou

27397 Jingshi Road
Jinan, 250022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Novel Clinical Intervention Pathway Based on the Pathogenesis Mechanism of Enterotoxigenic Bacteroides fragilis.

Novel Clinical Intervention Pathway Based on the Pathogenesis Mechanism of Enterotoxigenic Bacteroides fragilis.

Journal: Critical reviews in oncology/hematology

Published: April 14, 2026

NPHR, FPR, and PLT as predictors of ulcerative colitis severity: a single-center retrospective study in China.

NPHR, FPR, and PLT as predictors of ulcerative colitis severity: a single-center retrospective study in China.

Journal: Frontiers in medicine

Published: February 21, 2026

NEAT1 modulates neutrophil functions via glycolysis to restrain mucosal inflammation in ulcerative colitis.

NEAT1 modulates neutrophil functions via glycolysis to restrain mucosal inflammation in ulcerative colitis.

Journal: Frontiers in immunology

Published: February 02, 2026

The role of DAP12 in immune-related inflammatory diseases.

The role of DAP12 in immune-related inflammatory diseases.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: January 13, 2026

Research Progress on the Mechanism of Ginsenoside Rg1 in Inflammatory Bowel Disease.

Research Progress on the Mechanism of Ginsenoside Rg1 in Inflammatory Bowel Disease.

Journal: Journal of immunology research

Published: May 09, 2025

NUDT1 aggravates intestinal epithelial barrier injury through oxidative stress in ulcerative colitis.

NUDT1 aggravates intestinal epithelial barrier injury through oxidative stress in ulcerative colitis.

Journal: International immunopharmacology

Published: February 14, 2025

Si-Ni Decoction as a Potential Treatment for Ulcerative Colitis: Modulation of Gut Microbiota and AKT1 Inhibition Through Network Pharmacology and in vivo Validation.

Si-Ni Decoction as a Potential Treatment for Ulcerative Colitis: Modulation of Gut Microbiota and AKT1 Inhibition Through Network Pharmacology and in vivo Validation.

Journal: Journal of inflammation research

Published: January 27, 2025

Role of guanylate-binding protein 5 in inflammatory diseases, immune diseases, cancers, and its potential therapeutic implications.

Role of guanylate-binding protein 5 in inflammatory diseases, immune diseases, cancers, and its potential therapeutic implications.

Journal: Inflammopharmacology

Published: January 20, 2025

Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment.

Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment.

Journal: Mediators of inflammation

Published: January 08, 2025

A Rare Case of Small Bowel Ulceration Induced by COVID-19.

A Rare Case of Small Bowel Ulceration Induced by COVID-19.

Journal: Journal of inflammation research

Published: November 18, 2024

Spleen tyrosine kinase aggravates intestinal inflammation through regulating inflammatory responses of macrophage in ulcerative colitis.

Spleen tyrosine kinase aggravates intestinal inflammation through regulating inflammatory responses of macrophage in ulcerative colitis.

Journal: International immunopharmacology

Published: October 03, 2024

Targeted nuclear degranulation of neutrophils promotes the progression of pneumonia in ulcerative colitis.

Targeted nuclear degranulation of neutrophils promotes the progression of pneumonia in ulcerative colitis.

Journal: Precision clinical medicine

Published: July 27, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026